{
    "Trade/Device Name(s)": [
        "HemosIL Silica Clotting Time"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K050221",
    "Predicate Device Reference 510(k) Number(s)": [
        "K990302"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GFO"
    ],
    "Summary Letter Date": "March 30, 2005",
    "Summary Letter Received Date": "January 31, 2005",
    "Submission Date": "January 28, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.7925"
    ],
    "Regulation Name(s)": [
        "Partial thromboplastin time tests"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Lupus Anticoagulants"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems",
        "ACL Advance",
        "ACL Futura"
    ],
    "Method(s)/Technology(ies)": [
        "Screening reagent",
        "Confirmatory reagent",
        "Clotting time assay"
    ],
    "Methodologies": [
        "Coagulation testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Silica Clotting Time assay for detection of Lupus Anticoagulants using screening and confirmatory reagents on IL Coagulation Systems",
    "Indications for Use Summary": "Intended for the detection of Lupus Anticoagulants in human citrated plasma on the IL Coagulation Systems using screening and confirmatory reagents sensitized to phospholipid dependent antibodies",
    "fda_folder": "Hematology"
}